About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD11.6075804300128.1451
Domestic EquitiesDR REDDYS LABORATORIES LTD7.226671455579.7801
Domestic EquitiesAUROBINDO PHARMA LTD7.103474100078.4200
Domestic EquitiesCIPLA LTD6.247149000068.9675
Domestic EquitiesLUPIN LTD6.215036024068.6131
Domestic EquitiesDIVI LABORATORIES LTD5.210510496557.5234
Domestic EquitiesFORTIS HEALTHCARE LTD4.745785510052.3920
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD3.98227263543.9631
Domestic EquitiesZYDUS LIFESCIENCES LTD3.742247128741.3130
Domestic EquitiesASTER DM HEALTHCARE LTD3.310590699136.5472
Domestic EquitiesALKEM LABORATORIES LTD3.16697524934.9622
Domestic EquitiesWOCKHARDT LTD2.877027487131.7613
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD2.572556612128.3995
Domestic EquitiesLAURUS LABS LTD2.411650500026.6236
Domestic EquitiesAJANTA PHARMA LTD2.13339473723.5511
Domestic EquitiesTORRENT PHARMACEUTICALS LTD1.89397092120.9082
Domestic EquitiesIPCA LABORATORIES LTD1.748914245219.3072
Domestic EquitiesMEDI ASSIST HEALTHCARE SERVICES LTD1.713041867018.9113
Domestic EquitiesDR. AGARWALS HEALTH CARE LTD1.653445518718.2530
Domestic EquitiesFDC LTD1.630347128317.9983
Domestic EquitiesORCHID PHARMA LTD1.523417500016.8184
Domestic EquitiesDR. LAL PATH LABS LTD1.46507000016.1732
Domestic EquitiesJUPITER LIFE LINE HOSPITALS LTD1.383610638915.2743
Domestic EquitiesINDOCO REMEDIES LTD1.187066699213.1044
Domestic EquitiesMETROPOLIS HEALTHCARE LTD1.10717713412.2219
Domestic EquitiesAKUMS DRUGS AND PHARMACEUTICALS LTD1.061825735211.7224
Domestic EquitiesPIRAMAL PHARMA LTD1.026459670211.3308
Domestic EquitiesAMI ORGANICS LTD0.98225000010.8433
Domestic EquitiesCOROMANDEL INTERNATIONAL LTD0.90606000010.0017
Domestic EquitiesSANOFI INDIA LTD0.8699191649.6041
Domestic EquitiesMANKIND PHARMA LTD0.8599414469.4936
Domestic EquitiesSANOFI CONSUMER HEALTHCARE INDIA LTD0.7902191648.7242
Domestic EquitiesMEDPLUS HEALTH SERVICES LTD0.76901188088.4900
Domestic EquitiesPROCTER & GAMBLE HEALTH LTD0.7296160008.0545
Domestic EquitiesINVENTURUS KNOWLEDGE SOLUTIONS LTD0.6786417427.4916
Domestic EquitiesSYNGENE INTERNATIONAL LTD0.63261070466.9837
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD0.5513245886.0864
Domestic EquitiesDEEPAK NITRITE LTD0.3003179093.3155
Domestic EquitiesLAXMI DENTAL LTD0.0441143570.4871
Total 98.0594 1082.5613
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET1.5764 17.4038
Cash & Cash Equivalents and Net AssetsA) REPO0.3642 4.0206
Total 1.9406 21.4244
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.